Article Text


Radiofrequency ablation for resistant hypertension: a report of three cases
  1. Chengming Yang1,
  2. Peng Chen1,
  3. Kai Liao2,
  4. Yuqiang Fang1,
  5. Weibing Shi1,
  6. Ye Zhang1,
  7. Qiao Chen1,
  8. Xiaoqun Zhang1
  1. 1Department of Cardiology, Institute of Surgery Research, Daping Hospital, Third Military Medical University, Chongqing, China
  2. 2Department of Cardiology, Lusan Convalescent Hospital, Nanjing Military District, Jiujiang, China


Objective To evaluate the efficacy and safety of renal sympathetic denervation by radiofrequency ablation for patients with resistant hypertension and discuss the experience in the operation.

Methods Three patients with resistant hypertension received percutaneous radiofrequency catheter-based treatment with subsequent follow-up about half to 1 year. The authors assessment the blood-pressure lowering effectiveness and changes in antihypertensive drugs.

Result During follow-up of the three cases, the dosage and types of antihypertensive drugs were reduced in all three patients. The blood-pressure of two patients achieved normal level, while another showed no significant decrease.

Conclusion Percutaneous renal sympathetic denervation by radiofrequency ablation can potentially reduce the level of blood-pressure, dosage and types of antihypertensive drugs for resistant hypertensive patients.

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.